EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
   3.4.17.20 | bradykinin + H2O |
i.e. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
Homo sapiens |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe + Arg |
- |
? |
| 3.4.17.20 | complement component C3a octapeptide + H2O |
removal of terminal arginine, low activity |
Homo sapiens |
? |
- |
? |
| 3.4.17.20 | complement component C5a octapeptide + H2O |
removal of terminal arginine |
Homo sapiens |
? |
- |
? |
| 3.4.17.20 | Fibrin + H2O |
- |
Homo sapiens |
? |
- |
? |
| 3.4.17.20 | fibrin + H2O |
- |
Homo sapiens |
Lys + ? |
- |
? |
| 3.4.17.20 | fibrin + H2O |
attenuates clot lysis by removing lysine residues from a fibrin clot |
Homo sapiens |
Lys + ? |
- |
? |
| 3.4.17.20 | fibrin + H2O |
anti-fibrinolytic activity |
Homo sapiens |
fibrin + Lys |
- |
? |
| 3.4.17.20 | fibrin + H2O |
cleavage of C-terminal Lys, regulation, overview |
Mus musculus |
fibrin + Lys |
the cleaved fibrin cannot be bound by plasminogen and the plasminogen activator in contrast to the uncleaved fibrin, fibrinolysis and plasmin regulation cycle involving the enzyme, overview |
? |
| 3.4.17.20 | fibrin + H2O |
cleavage of C-terminal Lys, regulation, overview |
Homo sapiens |
fibrin + Lys |
the cleaved fibrin cannot be bound by plasminogen and the plasminogen activator in contrast to the uncleaved fibrin, fibrinolysis and plasmin regulation cycle involving the enzyme, overview |
? |
| 3.4.17.20 | fibrin + H2O |
partially degraded fibrin in fibrin clots, cleavage of C-terminal Lys |
Homo sapiens |
fibrin + Lys |
- |
? |
